NCT01377402

Brief Summary

The first aim of this trial is to assess the long-term prognostic value of Omega-3 index, which is a measure of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) relative to other fatty acids in the erythrocyte membrane, in an unselected, regional multicenter observational study of 982 chest pain patients admitted to the emergency unit, employing blood samples collected at admission. The second purpose of this study is to evaluate the prognostic utility of vitamin D in the same population. The third purpose of this study is to assess the incremental prognostic value of B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hsCRP).

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
982

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2005

Longer than P75 for all trials

Geographic Reach
2 countries

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2005

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 21, 2011

Completed
4.5 years until next milestone

Results Posted

Study results publicly available

December 17, 2015

Completed
Last Updated

May 2, 2017

Status Verified

March 1, 2017

Enrollment Period

5.1 years

First QC Date

June 20, 2011

Results QC Date

July 28, 2015

Last Update Submit

March 19, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total Mortality.

    Mortality for any reason

    2-5 years

Secondary Outcomes (1)

  • Participants With Cardiac Events During Follow-up.

    2-5 years

Study Arms (1)

Chest pain

Men and women admitted with chest pain and suspected acute coronary syndrome (ACS).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

982 men and women admitted with chest pain and potential acute cornary syndrome (ACS) at nine hopitals in Salta, Argenitna between November 2005 and November 2008.

You may qualify if:

  • adults \> 18 years able to give informed consent
  • a history of chest pain or other symptoms suggestive of an ACS leading to admission at the emergency unit

You may not qualify if:

  • \< 18 years of age
  • Unwillingness or incapacity to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Clinica Güemes

Salta, Salta Province, 4400, Argentina

Location

Clinica San Rafael

Salta, Salta Province, 4400, Argentina

Location

Hospital Militar Salta

Salta, Salta Province, 4400, Argentina

Location

Hospital Privado Santa Clara de Asis

Salta, Salta Province, 4400, Argentina

Location

Hospital San Bernardo

Salta, Salta Province, 4400, Argentina

Location

Intituto CENESA

Salta, Salta Province, 4400, Argentina

Location

Sanatorio El Carmen

Salta, Salta Province, 4400, Argentina

Location

Sanatorio El Parque

Salta, Salta Province, 4400, Argentina

Location

Sanatorio San Roque

Salta, Salta Province, 4400, Argentina

Location

Stavanger University Hospital

Stavanger, Rogaland, 4011, Norway

Location

Related Publications (8)

  • Leon de la Fuente R, Naesgaard PA, Nilsen ST, Woie L, Aarsland T, Gallo P, Grundt H, Staines H, Nilsen DW. B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovasc Disord. 2011 Sep 29;11:57. doi: 10.1186/1471-2261-11-57.

  • de la Fuente RL, Naesgaard PA, Nilsen ST, Woie L, Aarsland T, Gundersen T, Nilsen DW. Omega-3 index and prognosis in acute coronary chest pain patients with a low dietary intake of omega-3. Scand Cardiovasc J. 2013 Apr;47(2):69-79. doi: 10.3109/14017431.2012.747220. Epub 2012 Dec 12.

  • Leon de la Fuente RA, Naesgaard PA, Nilsen ST, Woie L, Aarsland T, Staines H, Nilsen DW. Socioeconomic assessment and impact of social security on outcome in patients admitted with suspected coronary chest pain in the city of salta, Argentina. Cardiol Res Pract. 2013;2013:807249. doi: 10.1155/2013/807249. Epub 2013 May 29.

  • Naesgaard PA, Leon de la Fuente RA, Nilsen ST, Woie L, Aarsland T, Staines H, Nilsen DW. Vitamin d predicts all-cause and cardiac mortality in females with suspected acute coronary syndrome: a comparison with brain natriuretic Peptide and high-sensitivity C-reactive protein. Cardiol Res Pract. 2013;2013:398034. doi: 10.1155/2013/398034. Epub 2013 Nov 17.

  • Nilsen DW, Mjelva OR, Leon de la Fuente RA, Naesgaard P, Ponitz V, Brugger-Andersen T, Grundt H, Staines H, Nilsen ST. Borderline Values of Troponin-T and High Sensitivity C-Reactive Protein Did Not Predict 2-Year Mortality in TnT Positive Chest-Pain Patients, Whereas Brain Natriuretic Peptide Did. Front Cardiovasc Med. 2015 Apr 8;2:16. doi: 10.3389/fcvm.2015.00016. eCollection 2015.

  • Aarsetoy R, Ueland T, Aukrust P, Michelsen AE, Leon de la Fuente R, Grundt H, Staines H, Nygaard O, Nilsen DWT. Complement component 7 is associated with total- and cardiac death in chest-pain patients with suspected acute coronary syndrome. BMC Cardiovasc Disord. 2021 Oct 14;21(1):496. doi: 10.1186/s12872-021-02306-w.

  • Aarsetoy R, Ueland T, Aukrust P, Michelsen AE, de la Fuente RL, Ponitz V, Brugger-Andersen T, Grundt H, Staines H, Nilsen DWT. Angiopoietin-2 and angiopoietin-like 4 protein provide prognostic information in patients with suspected acute coronary syndrome. J Intern Med. 2021 Oct;290(4):894-909. doi: 10.1111/joim.13339. Epub 2021 Jul 8.

  • Naesgaard PA, Leon De La Fuente RA, Nilsen ST, Woie L, Aarsland T, Brede C, Staines H, Nilsen DW. Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina. PLoS One. 2012;7(9):e43228. doi: 10.1371/journal.pone.0043228. Epub 2012 Sep 6.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum, Citrated plasma, EDTA-plasma and packed red blood cells are kept in suitable aliquots at -80 degrees Celcius.

MeSH Terms

Conditions

Chest PainCoronary Artery DiseaseAngina, UnstableMyocardial Infarction

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesAngina PectorisInfarctionIschemiaPathologic ProcessesNecrosis

Results Point of Contact

Title
Dennis WT Nilsen, MD, phd, professor
Organization
Stavanger University Hospital

Study Officials

  • Dennis WT Nilsen, MD PhD Prof.

    Helse Stavanger HF

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2011

First Posted

June 21, 2011

Study Start

November 1, 2005

Primary Completion

December 1, 2010

Study Completion

December 1, 2010

Last Updated

May 2, 2017

Results First Posted

December 17, 2015

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations